170 related articles for article (PubMed ID: 8588030)
1. Superparamagnetic nanoparticles as blood-pool contrast agents. Contribution to MRI preclinical investigations.
Benderbous S; Bonnemain B
Radiologe; 1995 Nov; 35(11 Suppl 2):S248-52. PubMed ID: 8588030
[No Abstract] [Full Text] [Related]
2. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.
Frija G; Clément O; Le Guen O; Cuénod CA; Siauve N; Benderbous S
Acad Radiol; 1996 Aug; 3 Suppl 2():S299-300. PubMed ID: 8796586
[No Abstract] [Full Text] [Related]
3. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
Clément O; Guimaraes R; de Kerviler E; Frija G
Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
[No Abstract] [Full Text] [Related]
4. [Overview of MRI contrast media. The case of endorem].
Duroux M
Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
[No Abstract] [Full Text] [Related]
5. MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.
Clement O; Rety F; Cuenod CA; Siauve N; Carnot F; Bordat C; Siche M; Frija G
Acad Radiol; 1998 Apr; 5 Suppl 1():S170-2; discussion S183-4. PubMed ID: 9561073
[No Abstract] [Full Text] [Related]
6. [Use of ultrasmall ferric oxide (Sinerem) particles as a magnetic resonance contrast substance for imaging lymph nodal metastases in cancer of the head and neck].
Sviridov NK; Napolov IuK; Bolotova EN; Iakobs LV
Vestn Rentgenol Radiol; 2004; (3):63-4. PubMed ID: 15587888
[No Abstract] [Full Text] [Related]
7. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
[TBL] [Abstract][Full Text] [Related]
9. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
Barentsz JO; Fütterer JJ; Takahashi S
Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
[TBL] [Abstract][Full Text] [Related]
10. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
Islam T; Wolf G
Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond.
Anzai Y
Top Magn Reson Imaging; 2004 Apr; 15(2):103-11. PubMed ID: 15269613
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
[TBL] [Abstract][Full Text] [Related]
14. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
[TBL] [Abstract][Full Text] [Related]
15. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
[TBL] [Abstract][Full Text] [Related]
16. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Montie JE
J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
[No Abstract] [Full Text] [Related]
17. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
Korosoglou G; Tang L; Kedziorek D; Cosby K; Gilson WD; Vonken EJ; Schär M; Sosnovik D; Kraitchman DL; Weiss RG; Weissleder R; Stuber M
J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
[TBL] [Abstract][Full Text] [Related]
18. Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography.
Tanimoto A; Yuasa Y; Hiramatsu K
Acad Radiol; 1998 Apr; 5 Suppl 1():S113-5. PubMed ID: 9561058
[No Abstract] [Full Text] [Related]
19. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
Harisinghani MG; Dixon WT; Saksena MA; Brachtel E; Blezek DJ; Dhawale PJ; Torabi M; Hahn PF
Radiographics; 2004; 24(3):867-78. PubMed ID: 15143236
[TBL] [Abstract][Full Text] [Related]
20. Investigation of atherosclerotic plaques with MRI at 3 T using ultrasmall superparamagnetic particles of iron oxide.
Priest AN; Ittrich H; Jahntz CL; Kooijman H; Weber C; Adam G
Magn Reson Imaging; 2006 Dec; 24(10):1287-93. PubMed ID: 17145399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
